Workflow
Factor XI
icon
Search documents
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript
Seeking Alphaยท 2025-11-10 19:31
PresentationWelcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Ryan Crowe, Senior Vice President, Investor Relations. You may begin.Ryan CroweSenior Vice President of Investor Relations & Strategic Analysis Thank you, Shannon. Good morning, and welcome to the inaugural Regeneron Roundtable Inves ...